Comparative analysis of G-banding, chromosome painting, locus-specific fluorescence in situ hybridization, and comparative genomic hybridization in chronic myeloid leukemia blast crisis

Cancer Genetics and Cytogenetics

Volumn 111, Issue 1, 1999, Pages 7-17

  Gribble, Susan M ^a   Sinclair, Paul B ^b   Grace, Colin ^c   Green, Anthony R ^a   Nacheva, Elizabeth P ^b  

^a UNIVERSITY OF CAMBRIDGE   (United Kingdom)

^b ADDENBROOKE S HOSPITAL   (United Kingdom)

^c Digital Scientific Ltd   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; BLAST CELL CRISIS; CHROMOSOME 8; CHROMOSOME BANDING PATTERN; CHROMOSOME DELETION; CHROMOSOME G BAND; CHROMOSOME LOSS; CHROMOSOME PAINTING; CHRONIC MYELOID LEUKEMIA; CLINICAL ARTICLE; COMPARATIVE GENOMIC HYBRIDIZATION; FLUORESCENCE IN SITU HYBRIDIZATION; GENE AMPLIFICATION; HUMAN; HUMAN CELL; INTERMETHOD COMPARISON; PRIORITY JOURNAL; TRISOMY 8; TUMOR SUPPRESSOR GENE;

ADOLESCENT; ADULT; AGED; BONE MARROW; CHROMOSOME ABERRATIONS; CHROMOSOME DELETION; CHROMOSOME DISORDERS; CHROMOSOME PAINTING; CHROMOSOMES, HUMAN, PAIR 8; FEMALE; GENES, TUMOR SUPPRESSOR; GENETIC MARKERS; HUMANS; IN SITU HYBRIDIZATION, FLUORESCENCE; LEUKEMIA, MYELOID, CHRONIC; LEUKOCYTES, MONONUCLEAR; MALE; MIDDLE AGED; NEOPLASM STAGING; NUCLEIC ACID HYBRIDIZATION;

EID: 0032929241     PISSN: 01654608     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0165-4608(98)00213-1     Document Type: Article

References (49)

1. Nowell P.C., Hungerford D.A. A minute chromosome in human granulocytic leukemia. Science. 132:1960;1497.
2. Rowley J.D. A new consistent chromosomal abnormality in chronic myelogenous leukaemia identified by quinacrine fluorescence and Giemsa staining [letter]. Nature. 243:1973;290-293.
3. Melo J.V. The molecular biology of chronic myeloid leukemia. Leukemia. 10:1996;751-756.
4. Sill H., Goldman J.M., Cross N.C. Homozygous deletions of the p16 tumor-suppressor gene are associated with lymphoid transformation of chronic myeloid leukemia. Blood. 85:1995;2013-2016.
5. Serra A., Gottardi E., Ragione F.D., Saglio G., Iolascon A. Involvement of the cyclin-dependent kinase-4 inhibitor (CDKN2) gene in the pathogenesis of lymphoid blast crisis of chronic myelogenous leukemia. Br J Haematol. 91:1995;625-629.
6. Stuppia L., Calabrese G., Peila R., Guanciali-Franchi P., Morizio E., Spadano A., Palka G. p53 loss and point mutations are associated with suppression of apoptosis and progression of CML into myeloid blastic crisis. Cancer Genet Cytogenet. 98:1997;28-35.
7. Serra A., Guerrasio A., Gaidano G., Rosso C., Rege-Cambrin G., Petroni D., Mazza U., Saglio G. Molecular defects associated with the acute phase CML. Leuk Lymphoma. 11:1993;25-28.
8. Jennings B.A. A study of changes in methylation status and copy number at the c-myc locus during the progression of chronic myeloid leukaemia. B J Haematol. 89(Suppl. 1):1995;37.
9. Heim S., Mitelman F. Cancer Cytogenetics. 1995;John Wiley & Sons, Inc. New York.
10. Mitani K., Ogawa S., Tanaka T., Miyoshi H., Kurokawa M., Mano H., Yazaki Y., Ohki M., Hirai H. Generation of the AML1-EVI-1 fusion gene in the t(3;21)(q26;q22) causes blastic crisis in chronic myelocytic leukemia. EMBO J. 13:1994;504-510.
11. Ogawa S., Kurokawa M., Tanaka T., Tanaka K., Hangaishi A., Mitani K., Kamada N., Yazaki Y., Hirai H. Increased Evi-1 expression is frequently observed in blastic crisis of chronic myelocytic leukemia. Leukemia. 10:1996;788-794.
12. Mori N., Morosetti R., Lee S., Spira S., Ben-Yehuda D., Schiller G., Landolfi R., Mizoguchi H., Koeffler H.-P. Allelotype analysis in the evolution of chronic myelocytic leukemia. Blood. 90:1997;2010-2014.
13. Ch'ang H.-J., Tien H.-F., Wang C.-H., Chuang S.-M., Chen Y.C., Shen M.-C., Lin D.-T., Lin K.-H. Comparison of clinical and biological features between myeloid and lymphoid transformation of Philadelphia chromosome positive chronic myeloid leukemia. Cancer Genet Cytogenet. 71:1993;87-93.
14. Bernstein R. Cytogenetics of chronic myelogenous leukemia. Sem Hematol. 25:1988;20-34.
15. Derderian P.M., Kantarjian H.M., Talpaz M., O'Brien S., Cork A., Estey E., Pierce S., Keating M. Chronic myelogenous leukemia in the lymphoid blastic phase. characteristics, treatment response, and prognosis Am J Med. 94:1993;69-74.
16. Gordon K.B., Thompson C.T., Char D.H., O'Brien J.M., Kroll S., Ghazvini S., Gray J.W. Comparative genomic hybridization in the detection of DNA copy number abnormalities in uveal melanoma. Cancer Res. 54:1994;4764-4768.
17. Ried T., Petersen I., Holtgreve Grez H., Speicher M.R., Schrock E., du Manoir S., Cremer T. Mapping of multiple DNA gains and losses in primary small cell lung carcinomas by comparative genomic hybridization. Cancer Res. 54:1994;1801-1806.
18. Kallioniemi A., Kallioniemi O.-P., Piper J., Tanner M., Stokke T., Chen L., Smith H.S., Pinkel D., Gray J.W., Waldman F.M. Detection and mapping of amplified DNA sequences in breast cancer by comparative genomic hybridisation. Proc Natl Acad Sci USA. 91:1994;2156-2160.
19. Visakorpi T., Kallioniemi A.H., Syvanen A.C., Hyytinen E.R., Karhu R., Tammela T., Isola J.J., Kallioniemi O.-P. Genetic changes in primary and recurrent prostate cancer by comparative genomic hybridization. Cancer Res. 55:1995;342-347.
20. Arnold N., Hagele L., Walz L., Schempp W., Pfisterer J., Bauknecht T., Kiechle M. Overrepresentation of 3q and 8q material and loss of 18q material are recurrent findings in advanced human ovarian cancer. Genes Chromosom Cancer. 16:1996;46-54.
21. Solinas-Toldo S., Wallrapp C., Muller Pillasch F., Bentz M., Gress T., Lichter P. Mapping of chromosomal imbalances in pancreatic carcinoma by comparative genomic hybridisation. Cancer Res. 56:1996;3803-3807.
22. Lastowska M., Nacheva E., McGuckin A., Curtis A., Grace C., Pearson A., Brown N. Comparative genomic hybridisation study of primary neuroblastoma tumors. Genes Chromosom Cancer. 18:1997;162-169.
23. Mohamed A.N., Macoska J.A., Kallioniemi A., Kallioniemi O.P., Waldman F., Ratanatharathorn V., Wolman S.R. Extrachromosomal gene amplification in acute myeloid leukemia. characterisation by metaphase analysis, comparative genomic hybridisation, and semi-quantitative PCR Genes Chromosom Cancer. 8:1993;185-189.
24. Bentz M., Huck K., du Manoir S., Joos S., Werner C.A., Fishcer K., Dohner H., Lichter P. Genomic hybridization in chronic B-cell leukaemias shows a high incidence of chromosomal gains and losses. Blood. 85:1995;3610-3618.
25. Bentz M., Dohner H., Huck K., Schutz B., Ganser A., Joos S., du Manoir S., Lichter P. Comparative genomic hybridization in the investigation of myeloid leukaemias. Genes Chromosom Cancer. 12:1995;193-200.
26. Nacheva E., Grace C., Holloway T.L., Green A.R. Comparative genomic hybridization in acute myeloid leukemia. a comparison with G-banding and chromosome painting Cancer Genet Cytogenet. 82:1995;9-16.
27. Shipley J., Weber-Hall S., Bridsall S. Loss of the chromosomal region 5q11-q31 in the myeloid cell line HL-60. characterization by comparative genomic hybridisation and fluorescence in situ hybridisation Genes Chromosom Cancer. 15:1996;182-186.
28. Pegoraro L., Matera L., Ritz J., Levis A., Palumbo A., Biagini G. Establishment of a Ph-positive human cell line (BV173). J Natl Cancer Inst. 70:1983;447-451.
29. Kallioniemi O.-P., Kallioniemi A., Piper J., Isola J., Walderman F.M., Gray J.W., Pinkel D. Optimizing comparative genomic hybridization for analysis of DNA sequence copy number changes in solid tumors. Genes Chromosom Cancer. 10:1994;231-243.
30. deManoir S. Quantitative analysis of comparative genomic hybridisation. Cytometry. 19:1995;27-41.
31. Nacheva E.P., Grace C.D., Bittner M., Ledbetter D.H., Jenkins R.B., Green A.R. Comparative genomic hybridisation. a comparison with molecular and cytogenetic analysis Cytogenet Cell Genet. 100:1998;93-105.
32. Parente F., Gaudray P., Carle G.F., Turc-Carel C. Experimental assessment of the detection limit of genomic amplification by comparative genomic hybridisation CGH. Cytogenet Cell Genet. 78:1997;65-68.
33. Alimena G., Dallapiccola B., Gastaldi R., Mandelli F., Brandt L., Mitelman F., Nilsson P.G. Chromosomal, morphological and clinical correlations in blastic crisis of chronic myeloid leukaemia. a study of 69 cases Scand J Haematol. 28:1982;103-117.
34. Nanjangud G., Kadam P.R., Saikia T., Bishey A.N., Kumar A., Gopal R., Chopra H., Nair C.N., Advani S.H. Karyotypic findings as an independent prognostic marker in chronic myeloid leukemia blast crisis. Leuk Res. 18:1994;385-392.
35. Anastasi J., Feng J., Le Beau M.M., Larson R.A., Rowley J.D., Vardiman J.W. The relationship between secondary chromosomal abnormalities and blast transformation in chronic myelogenous leukemia. Leukemia. 9:1995;628-633.
36. Ariyama T., Inazawa J., Uemura Y., Kakazu N., Maekawa T., Urase F., Irimajiri K., Horiuchi A., Nakamura Y., Abe T. Clonal origin of Philadelphia chromosome negative cells with trisomy 8 appearing during the course of alpha-interferon therapy for Ph positive chronic myelocytic leukemia. Cancer Genet Cytogenet. 81:1995;20-23.
37. Watmore A.E., Potter A.M., Sokol R.J., Wood J.K. Value of cytogenetic studies in prediction of acute phase CML. Cancer Genet Cytogenet. 14:1985;293-301.
38. Mosaffa H., Brizard A., Huret J.L., Brizard F., Lessard M., Guilhot F., Tanzer J. Trisomy 8q due to i(8q) or der(8) t(8;8) is a frequent lesion in T-prolymphocytic leukemia. four new cases and a review of the literature Br J Haematol. 86:1994;780-785.
39. Forozan F., Karhu R., Kononen J., Kallioniemi A., Kallioniemi O.-P. Genome screening by comparative genomic hybridisation. Trends Genet. 13:1997;405-409.
40. Levin N.A., Brzoska P.M., Warnock M.L., Gray J.W., Christman M.F. Identification of novel regions of altered DNA copy number in small cell lung tumors. Genes Chromosom Cancer. 13:1995;175-185.
41. Marchio A., Meddeb M., Pineau P., Danglot G., Tiollais P., Bernheim A., Dejean A. Recurrent chromosomal abnormalities in hepatocellular carcinoma detected by comparative genomic hybridisation. Genes Chromosom Cancer. 18:1997;59-65.
42. Mitelman F. Catalogue of Chromosome Aberrations in Cancer. 1991;John Wiley & Sons, Inc. New York.
43. Sessarego M., Panarello C., Coviello D.A., Boccaccio P., Ajmar F. Karyotype evolution in CML. high frequency of translocations other than the Ph Cancer Genet Cytogenet. 25:1987;73-80.
44. Huret J.L., Schoenwald M., Brizard A., Guilhot F., Vilmer E., Tanzer J. Chromosome 6p rearrangements appear to be secondary changes in various haematological malignancies. Leuk Res. 13:1989;819-824.
45. Miyamoto K. Chromosome abnormalities in patients with chronic myelocytic leukemia. Acta Med Okayama. 34:1980;367-382.
46. Smadja N., Krulik M., Genot J.Y., Audebert A.A., Debray J. Abnormality of chromosome number 1 in 3 cases of acute transformation of chronic myeloid leukemia [trans.]. Nouv Rev Fr Hematol. 26:1984;303-308.
47. Sonta S., Sandberg A.A. Chromosomes and causation of human cancer and leukemia. XXVIII. Value of detailed chromosome studies on larger numbers of cells in CML Am J Hematol. 41:1977;153-163.
48. Asimakopoulos F.A., Holloway T.L., Nacheva E.P., Scott M.A., Fenaux P., Green A.R. Detection of chromosome 20q deletions in bone marrow metaphases but not peripheral blood granulocytes in patients with myeloproliferative disorders or myelodysplastic syndromes. Blood. 87:1996;1561-1570.
49. Sinclair P.B., Green A.R., Grace C., Nacheva E.P. Improved sensitivity of BCR-ABL detection. a triple-probe three-color fluorescence in situ hybridisation system Blood. 90:1997;1395-1402.